Local EUS-guided injection of chemotherapeutic agents as adjuvant to systemic treatment: the first steps are made

Gastrointestinal Endoscopy

Volumn 65, Issue 3, 2007, Pages 454-456

  Micames, Carlos G ^a   Gress, Frank G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; FLUOROURACIL; GEMCITABINE; ONCOGEL; ONYX 015; PACLITAXEL; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER GENE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG FEVER; EDITORIAL; HUMAN; MALAISE; MULTIMODALITY CANCER THERAPY; NAUSEA; NONHUMAN; PANCREAS CANCER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; ENDOSONOGRAPHY; HUMANS; INJECTIONS, INTRALESIONAL; PANCREATIC NEOPLASMS; SWINE; TREATMENT OUTCOME;

EID: 33847026470     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2006.08.016     Document Type: Editorial

References (27)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Warshaw A.L., and Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 326 (1992) 455-465
3. Cameron J.L., Crist D.W., Sitzmann J.V., et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161 (1991) 120-125
4. Geer R.J., and Brennan M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165 (1993) 68-73
5. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4 (2000) 567-579
6. Trede M., Schwall G., and Saeger H.D. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 211 (1990) 447-458
7. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221 (1995) 721-733
8. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 (1999) 776-784
9. Tepper J., Nardi G., and Sutt H. Carcinoma of the pancreas: review of MGH experience from 1963 to 1973: analysis of surgical failure and implications for radiation therapy. Cancer 37 (1976) 1519-1524
10. Moertel C.G., Childs Jr. D.S., Reitemeier R.J., et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2 (1969) 865-867
11. Moertel C.G., Frytak S., Hahn R.G., et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: the Gastrointestinal Tumor Study Group. Cancer 48 (1981) 1705-1710
12. Kalser M.H., and Ellenberg S.S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903
13. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
14. Blackstock A.W., Bernard S.A., Richards F., et al. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol 17 (1999) 2208-2212
15. Blackstock A.W., Tepper J.E., Niedwiecki D., et al. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. Int J Gastrointest Cancer 34 (2003) 107-116
16. Joensuu T.K., Kiviluoto T., Karkkainen P., et al. Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 60 (2004) 444-452
17. Talamonti M.S., Catalano P.J., Vaughn D.J., et al. Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol 18 (2000) 3384-3389
18. Moriai T., Makino T.T., and Ishii K. Intratumoral treatment of pancreatic cancer with mitomycin-C adsorbed to activated carbon particles: a clinical trial on 15 cases. Anticancer Res 9 (1989) 1799-1804
19. Chang K.J., Nguyen P.T., Thompson J.A., et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 88 (2000) 1325-1335
20. Sangro B., Mazzolini G., Ruiz J., et al. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol 22 (2004) 1389-1397
21. Hecht J.R., Bedford R., Abbruzzese J.L., et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 9 (2003) 555-561
22. Farrell J.J., Senzer N., Hecht J.R., et al. Long-term data for EUS and percutaneous guided intratumoral TNFerade gene delivery combined with chemoradiation in the treatment of locally advanced pancreatic cancer. [abstract]. Gastrointest Endosc 63 (2006) Ab580
23. Matthes K., Mino-Kenudson M., Sahani D.V., et al. EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Gastrointest Endosc 65 (2007) 448-453
24. Macromed product opportunity-OncoGel. Available at: www.macromed.com/oncogel%2028Jan2004v6.pdf. Accessed July 14, 2006.
25. Linghu E., Matthes K., Mino-Kenudson M., et al. Feasibility of endoscopic ultrasound-guided OncoGel (ReGel/paclitaxel) injection into the pancreas in pigs. Endoscopy 37 (2005) 1140-1142
26. Rich T., Harris J., Abrams R., et al. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol 27 (2004) 51-56
27. Whitehead R.P., Jacobson J., Brown T.D., et al. Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study. J Clin Oncol 15 (1997) 2414-2419